Skip to content

In the BioHarmony Drug Report Database

Fosamprenavir

Lexiva, Telzir (fosamprenavir) is a small molecule pharmaceutical. Fosamprenavir was first approved as Lexiva on 2003-10-20. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections.
Trade Name Telzir
Common Name Fosamprenavir
Indication acquired immunodeficiency syndrome, hiv infections
Drug Class Antivirals: HIV protease inhibitors (saquinavir type); phosphoro-derivatives
Fosamprenavir
Get full access now